Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mid-trimester induced abortion: a review.

S Lalitkumar1, M Bygdeman, K Gemzell-Danielsson

  • 1Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska University Hospital/Karolinska Institute, Stockholm, Sweden.

Human Reproduction Update
|October 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Vilaprisan in the Treatment of Uterine Fibroids: Data from ASTEROID 5, a Phase 3 Multicenter Randomized Controlled Trial.

Journal of clinical medicine·2026
Same author

Sexual function following risk-reducing salpingo-oophorectomy: a prospective cohort study.

Sexual medicine·2024
Same author

Women's decision-making related to induced abortion - a cross sectional study during a period of Covid-19 pandemic, in Sweden.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2022
Same author

There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Estetrol-Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

10-year evaluation of the use of medical abortion through telemedicine: a retrospective cohort study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same journal

Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.

Human reproduction update·2026
Same journal

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Human reproduction update·2026
Same journal

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.

Human reproduction update·2026
Same journal

Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Human reproduction update·2026
Same journal

Maternal genetic variants associated with aneuploid conception: a narrative review.

Human reproduction update·2026
Same journal

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
See all related articles

Mid-trimester abortion methods are evolving, with medical options like mifepristone and misoprostol becoming safer and more accessible. Further research is needed to establish guidelines for safety, acceptability, and pain management in abortion procedures.

Area of Science:

  • Reproductive Health
  • Gynecology
  • Medical Technology

Background:

  • Mid-trimester abortion accounts for 10-15% of all induced abortions.
  • Continuous efforts aim to enhance abortion technologies for effectiveness, ease of use, and reduced side effects.
  • Medical methods for mid-trimester abortion have significantly advanced in safety and accessibility over the past decade.

Purpose of the Study:

  • To review current literature on mid-trimester abortion methods.
  • To compare efficacy, side effects, and acceptability of different abortion procedures.
  • To identify gaps in research, particularly concerning pain management and safety in specific patient populations.

Main Methods:

  • Literature review of mid-trimester abortion techniques.

Related Experiment Videos

  • Discussion of medical (mifepristone and misoprostol) versus surgical abortion methods.
  • Analysis of existing data on safety, efficacy, and patient acceptability.

    • Main Results:

    • The combination of mifepristone and misoprostol is an established, highly effective method for termination of pregnancy (TOP).
    • Medical methods offer advantages in safety and accessibility compared to some surgical approaches.
    • Limited randomized studies exist, with scarce data on pain management and safety for patients with prior uterine scars.

    Conclusions:

    • Medical abortion methods, particularly mifepristone-misoprostol, are safe and effective for mid-trimester termination of pregnancy.
    • There is a critical need for more randomized controlled trials to establish definitive guidelines for mid-trimester abortion.
    • Further research should focus on optimizing pain management strategies and assessing the safety of abortion methods in women with previous uterine scars.